Nifty Pharma Prediction for Tomorrow, Wednesday 5 August 2026: Index at 21,628 Hits Headwinds from Dr Reddy’s Q1 Miss Pre-RBI
- August 4, 2026
- Posted by: Kunal Singla
- Category: News
Nifty Pharma Tue: 21,628 (-1.0%). Day range: 21,500-21,790. Support 21,450-21,500. Resistance 21,850-21,900. RBI 5 Aug 10 AM IST.
The Nifty Pharma prediction for tomorrow for Wednesday 5 August 2026 comes after Tuesday’s cautious session where the Nifty 50 fell 159 points or 0.64 percent to 24,614.90 as Tehran denied US-Iran peace talks, sending Brent crude recovering from 82 US dollars to approximately 84 US dollars. Bank Nifty fell approximately 1.3 percent as banks led the decline with HDFC Bank and Axis Bank among top losers. India VIX rose to approximately 13.15, reflecting pre-RBI anxiety. The dominant event for the Nifty Pharma prediction for tomorrow is the Reserve Bank of India Monetary Policy Committee rate decision at 10 AM IST Wednesday, with a unanimous hold at 5.25 percent widely expected. Nifty Pharma fell 1.0 percent Tuesday as Dr Reddy’s Laboratories crashed 9 percent to a 52-week low on Q1 FY27 results disappointment. Dr Reddy’s is one of the five largest Nifty Pharma constituents and its sector-leading decline created contagion selling in other large pharma stocks. Sun Pharma, the largest constituent, held relatively better given its own strong Q1 FY27 results. The Nifty Pharma prediction for tomorrow depends on whether Dr Reddy’s sell-off stabilises or continues, and whether Sun Pharma can counterbalance the negative sector sentiment. Ankit Jaiswal, Senior Research Analyst at Univest, and Kunal Singla, Associate Director at Univest, present the complete Nifty Pharma prediction for tomorrow outlook covering technical levels, global cues and three stocks to watch.
Click Here – Get Free Investment Predictions
Tuesday’s Session Data
| Indicator | Tuesday 4 Aug Close | Change |
|---|---|---|
| Nifty Pharma | 21,628 | -1.0% |
| Day Range | 21,500-21,790 | Session high/low |
| Nifty 50 | 24,614.90 | -159 pts (-0.64%) |
| Bank Nifty | ~57,485 | ~-762 pts (-1.3%) |
| India VIX | ~13.15 | +10.4% (pre-RBI anxiety) |
| Brent Crude | ~$84/bbl | +$2 (Tehran denied Iran talks) |
| Bharti Airtel Q1 FY27 | ARPU Rs 261 (+2%) | After-hours positive |
Ankit Jaiswal notes that the Nifty Pharma prediction for tomorrow is informed by Tuesday’s macro reversal: Tehran’s denial of US-Iran peace talks partially unwound Monday’s sharp crude oil crash, with Brent recovering from 82 US dollars to approximately 84 US dollars. The Nifty Pharma is the sectoral benchmark tracked for the Nifty Pharma prediction for tomorrow. Oil-linked stocks gained while FMCG and auto stocks gave back some of Monday’s crude-driven gains, setting the base for the Nifty Pharma prediction for tomorrow.
Technical Levels for the Nifty Pharma prediction for tomorrow
| Level Type | Zone |
|---|---|
| Immediate Support | 21,450-21,500 |
| Support 2 | 21,200-21,250 |
| Strong Support | 20,800-20,900 (50 DMA) |
| Immediate Resistance | 21,850-21,900 |
| Key Resistance | 22,200-22,400 |
Kunal Singla notes that the Nifty Pharma prediction for tomorrow rests on immediate support 21,450-21,500 holding through Wednesday’s pre-RBI window from 9:15 AM to 10:00 AM IST. On RBI decision days, markets range-trade for the first 45 minutes before the announcement triggers a directional move of 1 to 2 percent. Ankit Jaiswal places 21,850-21,900 as the key resistance for the Nifty Pharma prediction for tomorrow that must be cleared post-10 AM for the bullish case to be confirmed. Bharti Airtel’s strong Q1 FY27 results with ARPU Rs 261 and PAT growth of approximately 35 percent provide a positive pre-market bias for the Nifty Pharma prediction for tomorrow.
RBI MPC Impact on the Nifty Pharma prediction for tomorrow
The RBI Monetary Policy Committee announces its rate decision at 10 AM IST on Wednesday 5 August. All six MPC members are expected to vote for a hold at 5.25 percent. The Nifty Pharma prediction for tomorrow is binary: a hold with neutral guidance would produce a relief bounce; a dovish signal would be a strongly positive catalyst for the Nifty Pharma prediction for tomorrow; a hawkish surprise would revise the outlook bearishly within minutes. Ankit Jaiswal recommends treating the 10 AM announcement as the reset point for all intraday positions in the Nifty Pharma prediction for tomorrow.
Key Factors Shaping the Nifty Pharma prediction for tomorrow
- Dr Reddy’s Laboratories falling 9 percent to a 52-week low on Q1 FY27 results miss is the primary catalyst in the Nifty Pharma prediction for tomorrow. US generic pricing pressure and margin compression drove the result weakness.
- Sun Pharma held better than the sector Tuesday given its own 27 percent Q1 net profit growth. As the largest Nifty Pharma constituent, Sun Pharma’s relative resilience provides a counterbalancing positive for the Nifty Pharma prediction for tomorrow.
- A softening US dollar at approximately 95.59 continues to support rupee realizations for generic drug exporters, which is a structural positive for the majority of Nifty Pharma constituents in the Nifty Pharma prediction for tomorrow.
Stocks to Watch Wednesday
Univest analysts flag these three stocks for educational observation in the Nifty Pharma prediction for tomorrow. These are not buy recommendations.
Sun Pharma: CMP Rs 1,772. Ankit Jaiswal flags entry Rs 1,752-1,768, target Rs 1,822, SL Rs 1,725. Sun Pharma’s 27 percent Q1 net profit growth counterbalances Dr Reddy’s weakness and makes it the primary recovery play in the Nifty Pharma prediction for tomorrow.
Cipla: CMP Rs 1,638. Kunal Singla flags entry Rs 1,618-1,635, target Rs 1,688, SL Rs 1,592. Cipla’s diversified India and US portfolio provides broad sector coverage beyond the Dr Reddy’s company-specific issue in the Nifty Pharma prediction for tomorrow.
Apollo Hospitals: CMP Rs 7,188. Ankit Jaiswal flags entry Rs 7,120-7,178, target Rs 7,400, SL Rs 6,988. Apollo Hospitals provides domestic healthcare services exposure insulated from US generic drug pricing risks in the Nifty Pharma prediction for tomorrow.
Use the Univest Screener to Find Opportunities Aligned With the Nifty Pharma prediction for tomorrow
Strategy for the Nifty Pharma prediction for tomorrow
- 21,450-21,500 is the primary support for the Nifty Pharma prediction for tomorrow.
- 21,850-21,900 is the first resistance for the Nifty Pharma prediction for tomorrow. Ankit Jaiswal recommends booking here.
- Monitor Sun Pharma open price Wednesday as the largest constituent and the primary counterbalancing force to Dr Reddy’s weakness in the Nifty Pharma prediction for tomorrow.
- Watch for any Dr Reddy’s management clarification or analyst rebuttals that could stabilise the stock and reduce contagion in the Nifty Pharma prediction for tomorrow.
Risks to Monitor
- Dr Reddy’s Q1 miss creating continued contagion selling across Nifty Pharma constituents and deepening the Nifty Pharma prediction for tomorrow decline.
- US FDA warning letters on Indian pharma manufacturing plants creating additional sector headwinds in the Nifty Pharma prediction for tomorrow.
- Dollar strengthening from RBI hawkish signal reducing US generic export realizations across the Nifty Pharma prediction for tomorrow.
Conclusion
The Nifty Pharma prediction for tomorrow for Wednesday 5 August 2026 reflects -1.0% to 21,628 on Tuesday, as Tehran denied Iran peace talks and crude recovered to approximately 84 US dollars, raising pre-RBI caution. Ankit Jaiswal of Univest places support for the Nifty Pharma prediction for tomorrow at 21,450-21,500 and resistance at 21,850-21,900. The RBI MPC decision at 10 AM IST Wednesday is the single most important catalyst for the Nifty Pharma prediction for tomorrow. Check GIFT Nifty and Airtel pre-market at 9 AM to set the opening scenario.
Kunal Singla of Univest notes that with India VIX at approximately 13.15, the Nifty Pharma prediction for tomorrow carries wider intraday volatility than a typical session. A neutral RBI hold would produce a contained 150-200 point Nifty swing consistent with the Nifty Pharma prediction for tomorrow base case. Traders should honour stop losses and avoid large positions before 10 AM RBI clarity in the Nifty Pharma prediction for tomorrow.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com), BSE (bseindia.com) and MCX (mcxindia.com) websites before making any investment decision. Investments in securities and commodities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Download the Univest iOS App or Univest Android App to track live levels and RBI day alerts for the this prediction.
FAQs on this prediction
What is the this prediction, Wednesday 5 August 2026?
Ans. The this prediction is cautiously neutral with a downside bias. The index closed Tuesday at 21,628, down 1.0 percent, led by Dr Reddy’s 9 percent Q1 miss. Support is 21,450-21,500 and resistance 21,850-21,900 in the this prediction. Sun Pharma’s strong Q1 provides a counterbalancing positive for the this prediction.
Which analysts prepared the this prediction?
Ans. Ankit Jaiswal, Senior Research Analyst, and Kunal Singla, Associate Director at Univest, prepared the this prediction.
How does Dr Reddy’s Q1 miss affect the this prediction?
Ans. Dr Reddy’s 9 percent decline to a 52-week low on Q1 FY27 results created contagion selling in the pharma sector. As one of the five largest Nifty Pharma constituents, its sharp fall dragged the index 1.0 percent lower and created the primary headwind in the this prediction.
What is Nifty Pharma support and resistance for the prediction for tomorrow?
Ans. Support is 21,450-21,500 and 21,200-21,250. The 50 DMA at 20,800-20,900 is the medium-term floor. Resistance is 21,850-21,900 and 22,200-22,400 in the this prediction.
What stocks are watched in the this prediction?
Ans. Sun Pharma (largest constituent, strong Q1 counterbalance), Cipla (diversified portfolio) and Apollo Hospitals (domestic demand insulation) are the three stocks in the this prediction.
